BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun S, Shang E, Ju A, Li Y, Wu Q, Li Q, Yang Y, Guo Y, Yang D, Lv S. Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study. Fitoterapia 2021;155:105033. [PMID: 34517057 DOI: 10.1016/j.fitote.2021.105033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Calvo-martín G, Plano D, Martínez-sáez N, Aydillo C, Moreno E, Espuelas S, Sanmartín C. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments. Pharmaceuticals 2022;15:1465. [DOI: 10.3390/ph15121465] [Reference Citation Analysis]
2 Xu Y, Wang M, Ning S, Yang Z, Zhou L, Xia X. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma. Molecules 2022;27:6786. [DOI: 10.3390/molecules27206786] [Reference Citation Analysis]
3 Leung KS, Shirazi S, Cooper LF, Ravindran S. Biomaterials and Extracellular Vesicle Delivery: Current Status, Applications and Challenges. Cells 2022;11:2851. [DOI: 10.3390/cells11182851] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Foglizzo V, Marchiò S. Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy. Cancers (Basel) 2022;14:2473. [PMID: 35626078 DOI: 10.3390/cancers14102473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]